BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17178334)

  • 1. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support.
    Felkin LE; Birks EJ; George R; Wong S; Khaghani A; Yacoub MH; Barton PJ
    J Heart Lung Transplant; 2006 Dec; 25(12):1413-9. PubMed ID: 17178334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure.
    Barton PJ; Birks EJ; Felkin LE; Cullen ME; Koban MU; Yacoub MH
    J Heart Lung Transplant; 2003 Jul; 22(7):738-44. PubMed ID: 12873541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices.
    Li YY; Feng Y; McTiernan CF; Pei W; Moravec CS; Wang P; Rosenblum W; Kormos RL; Feldman AM
    Circulation; 2001 Sep; 104(10):1147-52. PubMed ID: 11535571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of mechanical unloading on structural and nonstructural components of the extracellular matrix in advanced human heart failure.
    Sakamuri SS; Takawale A; Basu R; Fedak PW; Freed D; Sergi C; Oudit GY; Kassiri Z
    Transl Res; 2016 Jun; 172():30-44. PubMed ID: 26963743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
    Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles.
    Polyakova V; Loeffler I; Hein S; Miyagawa S; Piotrowska I; Dammer S; Risteli J; Schaper J; Kostin S
    Int J Cardiol; 2011 Aug; 151(1):18-33. PubMed ID: 20546954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.
    Felkin LE; Lara-Pezzi E; George R; Yacoub MH; Birks EJ; Barton PJ
    J Heart Lung Transplant; 2009 Feb; 28(2):117-22. PubMed ID: 19201335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
    Mukherjee R; Herron AR; Lowry AS; Stroud RE; Stroud MR; Wharton JM; Ikonomidis JS; Crumbley AJ; Spinale FG; Gold MR
    Am J Cardiol; 2006 Feb; 97(4):532-7. PubMed ID: 16461051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between myocardial redox state and matrix metalloproteinase activity in patients on left ventricular assist device support.
    Caruso R; Caselli C; Boroni C; Campolo J; Milazzo F; Cabiati M; Russo C; Parolini M; Giannessi D; Frigerio M; Parodi O
    Circ J; 2011; 75(10):2387-96. PubMed ID: 21817815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of MMP/TIMP and TGF-β1 Receptors throughout the Clinical Progression of Chronic Venous Disease.
    Serralheiro P; Novais A; Cairrão E; Maia C; Costa Almeida CM; Verde I
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices.
    Birks EJ; Latif N; Owen V; Bowles C; Felkin LE; Mullen AJ; Khaghani A; Barton PJ; Polak JM; Pepper JR; Banner NR; Yacoub MH
    Circulation; 2001 Sep; 104(12 Suppl 1):I233-40. PubMed ID: 11568062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury.
    Prakobwong S; Pinlaor S; Yongvanit P; Sithithaworn P; Pairojkul C; Hiraku Y
    Int J Parasitol; 2009 Jun; 39(7):825-35. PubMed ID: 19168069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of extracellular matrix remodelling are differentially expressed in paediatric and adult dilated cardiomyopathy.
    Hsia TY; Ringewald JM; Stroud RE; Forbus GA; Bradley SM; Chung WK; Spinale FG
    Eur J Heart Fail; 2011 Mar; 13(3):271-7. PubMed ID: 21147820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
    Wang W; Zhang HT; Yang XL
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal changes in myocardial collagen, matrix metalloproteinases, and their tissue inhibitors in the left ventricular myocardium in experimental chronic mitral regurgitation in rodents.
    Corporan D; Onohara D; Hernandez-Merlo R; Sielicka A; Padala M
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1269-H1278. PubMed ID: 30141979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression.
    Polyakova V; Hein S; Kostin S; Ziegelhoeffer T; Schaper J
    J Am Coll Cardiol; 2004 Oct; 44(8):1609-18. PubMed ID: 15489093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.
    Fielitz J; Leuschner M; Zurbrügg HR; Hannack B; Pregla R; Hetzer R; Regitz-Zagrosek V
    J Mol Med (Berl); 2004 Dec; 82(12):809-20. PubMed ID: 15558223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke.
    Lenglet S; Montecucco F; Mach F; Schaller K; Gasche Y; Copin JC
    Thromb Haemost; 2014 Aug; 112(2):363-78. PubMed ID: 24671655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.